DI BELLA FOUNDATION
>
DOCUMENTATION INDEX > Patient Area - Documents
Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma.
(12/04/2011)
Detail
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
(12/04/2011)
Detail
In vivo functional and anatomic imaging for assessment of in vivo gene transfer.
(12/04/2011)
Detail
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.
(12/04/2011)
Detail
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability.
(12/04/2011)
Detail
Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist,
(12/04/2011)
Detail
Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.
(12/04/2011)
Detail
DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model.
(12/04/2011)
Detail
Laryngeal paragangliomas - controversies in diagnosis and management.
(12/04/2011)
Detail
Value of 123I-MIBG Scintigraphy in Paraganglioma.
(12/04/2011)
Detail
Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
(12/04/2011)
Detail
Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
(12/04/2011)
Detail
Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy.
(12/04/2011)
Detail
Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.
(12/04/2011)
Detail
Retinoids activate RXR/CAR-mediated pathway and induce CYP3A.
(12/04/2011)
Detail